Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

GlobeNewsWire

14 Jul 2026, 07:30 UTC · 3h ago

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

Which stocks this story touches

How each ticker is affected

DXCM+0.20
The company's G7 device is integrated into ViCentra's launched Kaleido system.
BSX+0.00
Mentioned only in the context of a past acquisition of Nalu Medical.
JNJ+0.00
Mentioned only as the former employer of a new board member.
MDT+0.00
Mentioned only in the context of a past acquisition of Intersect ENT.
HOYA+0.00
Mentioned only as the former employer of the new CFO.
SIBN+0.00
Mentioned only to note a board member's current directorship.

Connected tickers

6 related stories

Business Wire
14h ago
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
- healthcare
- medical devices
- DXCM
Read

ViCentra Appoints Ian Wel… — DXCM +0.20 | NewsImpactScreener

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

How each ticker is affected

Connected tickers

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

How each ticker is affected

Connected tickers

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

First Phosphate closes final tranche of private placement, raises total of C$17.7M

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

How each ticker is affected

Connected tickers

Next reads from the same story arc

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

How each ticker is affected

Connected tickers

Next reads from the same story arc

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

First Phosphate closes final tranche of private placement, raises total of C$17.7M

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry